retatrutide and tirzepatide vs. Tirzepatide: The Next-Gen GLP-1 Showdown Switching from tirzepatide to retatrutide:

Glucagon-like peptide 1 (GLP-1) receptor agonist, treatment for type 2 diabetes

A maximum-strength premium drug arriving into that fight will launch with insurance restrictions, not open arms

There are several reasons why someone might choose to take GLP drugs, ranging from goals such as weight loss and improved heart health, to medical conditions like type 2 diabetes

A related theme in current bench science is the integration of endocrine signaling perturbations with mitochondrial and cellular energy readouts

These studies, however, did not examine the pathway in detail and presumed that cAMP acted through its canonical kinase, PKA, to cause the release of GLP-1

Retatrutide activates three (GLP-1 + GIP + glucagon)